NEW YORK, May 29, 2018 /PRNewswire/ -- Moore Kuehn,
PLLC is investigating potential claims for breach of fiduciary duty
involving the directors and officers of Akorn, Inc. (NASDAQ:
AKRX). On February 26, 2018
Fresenius SE & Co. KGaA ("Fresenius") announced it is
conducting an investigation into alleged breaches of FDA data
integrity requirements at Akorn Inc. Shareholders may be
entitled to certain corporate governance reforms.
According to a federal securities lawsuit, Akorn insiders caused
the company to make false and/or misleading statements and/or
failed to disclose that: (1) Akorn's failure to comply with FDA
data integrity requirements would jeopardize Fresenius's
acquisition of Akorn; (2) the Company lacked effective internal
controls over financial reporting; and (3) as a result, the
Company's financial statements were materially false and misleading
at all relevant times.
Moore Kuehn encourages shareholders of Akorn to contact
Justin Kuehn, Esq. by email at
jkuehn@moorekuehn.com or telephone at (212) 709-8245. There
is no cost or obligation to you.
Moore Kuehn is a New York-based
law firm with attorneys representing investors and consumers in
class action litigation involving securities law violations,
financial fraud, breaches of fiduciary duties, and other
claims. For additional information about Moore Kuehn, please
go to www.moorekuehn.com. Attorney advertising. Prior results
do not guarantee similar outcomes.
Contacts:
Moore Kuehn, PLLC
Justin Kuehn, Esq.
30 Wall Street, 8th Floor
New York, New York 10005
jkuehn@moorekuehn.com
(212) 709-8245
View original content with
multimedia:http://www.prnewswire.com/news-releases/moore-kuehn-pllc-announces-an-investigation-involving-possible-breaches-of-fiduciary-duties-by-officers-and-directors-of-akorn-inc-300655928.html
SOURCE Moore Kuehn, PLLC